Breast Cancer News and Research

Latest Breast Cancer News and Research

Researchers discover new aspect of gene regulation

Researchers discover new aspect of gene regulation

Weill Cornell scientists reveal how XBP1 gene can trigger immune responses against ovarian tumors

Weill Cornell scientists reveal how XBP1 gene can trigger immune responses against ovarian tumors

Daily dose of aspirin effective at blocking breast tumor growth

Daily dose of aspirin effective at blocking breast tumor growth

Certain ARID1a mutations sensitize some tumors to PARP inhibitor drugs

Certain ARID1a mutations sensitize some tumors to PARP inhibitor drugs

USC Stem Cell scientist named 2015 Pew-Stewart scholar for cancer research

USC Stem Cell scientist named 2015 Pew-Stewart scholar for cancer research

New gene mutations in ADAMTS family may contribute to outcomes in ovarian cancer

New gene mutations in ADAMTS family may contribute to outcomes in ovarian cancer

Pre-diagnostic short sleep duration, frequent snoring associated with poor cancer-specific survival

Pre-diagnostic short sleep duration, frequent snoring associated with poor cancer-specific survival

New study shows that estrogen receptors vanish in cervical cancer tumors

New study shows that estrogen receptors vanish in cervical cancer tumors

Findings could lead to new therapies that stop breast cancer progression

Findings could lead to new therapies that stop breast cancer progression

University at Albany researcher receives $1.76 million NIH grant to explore role of vitamin D in breast cancer

University at Albany researcher receives $1.76 million NIH grant to explore role of vitamin D in breast cancer

PALOMA3 supports palbociclib use in advanced breast cancer

PALOMA3 supports palbociclib use in advanced breast cancer

Actavis receives FDA approval to market NATRELLE INSPIRA round gel-filled textured breast implants

Actavis receives FDA approval to market NATRELLE INSPIRA round gel-filled textured breast implants

CASI files application with CFDA to conduct ENMD-2076 Phase 2 trial in fibrolamellar carcinoma patients

CASI files application with CFDA to conduct ENMD-2076 Phase 2 trial in fibrolamellar carcinoma patients

New strategy involving three-pronged approach may keep lung cancer aside

New strategy involving three-pronged approach may keep lung cancer aside

Wistar Institute scientists find new biomarker that appears to be more accurate at detecting NSCLC

Wistar Institute scientists find new biomarker that appears to be more accurate at detecting NSCLC

Novel strategy shows aptamer-based modular delivery of microRNA in endothelial, breast cancer cells

Novel strategy shows aptamer-based modular delivery of microRNA in endothelial, breast cancer cells

Breast surgery for low-grade ductal carcinoma in-situ may not change patients' survival rate

Breast surgery for low-grade ductal carcinoma in-situ may not change patients' survival rate

New research draws on support from patients and public to investigate impact of cardiac surgery

New research draws on support from patients and public to investigate impact of cardiac surgery

Genentech, Seragon, Regeneron and Avalanche receive Allicense 2015 Breakthrough Award for Deals of the Year

Genentech, Seragon, Regeneron and Avalanche receive Allicense 2015 Breakthrough Award for Deals of the Year

Majority of breast cancer patients unaware of the effect of double mastectomy

Majority of breast cancer patients unaware of the effect of double mastectomy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.